Dr. Steven Powell, MD
Claim this profileSanford Cancer Center
Studies Cancer
Studies Solid Tumors
10 reported clinical trials
36 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
2Solid Tumors
Stage IV
PD-L1 positive
Stage III
Affiliated Hospitals
Clinical Trials Steven Powell, MD is currently running
Voyager V1 + Cemiplimab
for Melanoma
This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are progressing on CPI treatment.
Recruiting1 award Phase 2
Targeted Therapy
for Advanced Stage Cancer
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
Recruiting1 award Phase 29 criteria
More about Steven Powell, MD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Steven Powell, MD has experience with
- Nivolumab
- Pembrolizumab
- BMS-986218
- Ipilimumab
- STI-6643
- Atezolizumab And PHESGO
Breakdown of trials Steven Powell, MD has run
Cancer
Solid Tumors
Lung Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven Powell, MD specialize in?
Steven Powell, MD focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Steven Powell, MD currently recruiting for clinical trials?
Yes, Steven Powell, MD is currently recruiting for 3 clinical trials in Sioux Falls South Dakota. If you're interested in participating, you should apply.
Are there any treatments that Steven Powell, MD has studied deeply?
Yes, Steven Powell, MD has studied treatments such as Nivolumab, Pembrolizumab, BMS-986218.
What is the best way to schedule an appointment with Steven Powell, MD?
Apply for one of the trials that Steven Powell, MD is conducting.
What is the office address of Steven Powell, MD?
The office of Steven Powell, MD is located at: Sanford Cancer Center, Sioux Falls, South Dakota 57104 United States. This is the address for their practice at the Sanford Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.